<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01535404</url>
  </required_header>
  <id_info>
    <org_study_id>CRM-CH-Riv01</org_study_id>
    <nct_id>NCT01535404</nct_id>
  </id_info>
  <brief_title>Right Versus Left Apical Transvenous Pacing for Patients With Preserved Left Ventricular Systolic Function Study</brief_title>
  <acronym>RIVELA</acronym>
  <official_title>Right Versus Left Apical Transvenous Pacing for Patients With Preserved Left Ventricular Systolic Function (RIVELA) Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Haran Burri, MD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>St. Jude Medical</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Geneva</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare chronic (1-year) effects on left ventricular ejection
      fraction resulting from transvenous pacing of the right ventricular apex (RVA) versus the
      left ventricular apex (LVA) in patients with preserved or mildly reduced left ventricular
      systolic function (&gt;= 45%).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It is well established that chronic right ventricular apical pacing has an adverse effect on
      left ventricular systolic function. An alternative is pacing the left ventricular apex, which
      has shown more favourable results in terms of left ventricular pump function than the RVA in
      small series. The left ventricular apex may be paced via the coronary sinus tributary (e.g.
      in the anterior cardiac vein). Our study will compare effects of these two pacing sites on
      left ventricular ejection fraction measured by 3D-echocardiography.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Slow enrollment
  </why_stopped>
  <start_date>January 2012</start_date>
  <completion_date type="Actual">May 2016</completion_date>
  <primary_completion_date type="Actual">May 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction in LVEF</measure>
    <time_frame>baseline to one year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in left ventricular end-systolic and end-diastolic volumes</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dyssynchrony evaluation during RV and LV pacing</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in tricuspid regurgitation severity, if any</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in mitral regurgitation severity, if any</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of device-related complications</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Success rate of autocapture algorithm for left-and right-ventricular pacing</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality and all cause hospitalization</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction of LVEF at 1 year compared to baseline according to the following pre-specified subgroups: a) initial LVEF, b) gender, c)etiology (coronary artery disease, nonischemic cardiomyopathy)</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">36</enrollment>
  <condition>Bradyarrhythmia</condition>
  <arm_group>
    <arm_group_label>Right ventricular apex pacing</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Left ventricular apex pacing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Implantation procedure for a St-Jude Medical pacemaker system with right ventricular apex pacing</intervention_name>
    <description>Implantation procedure for a St-Jude Medical pacemaker system with a transvenous ventricular and if applicable a right atrial lead</description>
    <arm_group_label>Right ventricular apex pacing</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Implantation procedure for a St-Jude Medical pacemaker system with left ventricular apex pacing</intervention_name>
    <description>Implantation procedure for a St-Jude Medical pacemaker system with a transvenous left ventricular (coronary sinus) and if applicable a right atrial lead</description>
    <arm_group_label>Left ventricular apex pacing</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Requirement for ventricular pacing according to current guidelines (including chronic
             atrial fibrillation)

          -  Anticipated &gt;=50% daily ventricular pacing

          -  LVEF &gt;=45% as evaluated by 2D-echocardiography, 3D-echocardiography, magnetic
             resonance imaging or by radionuclide/contrast ventriculography

          -  Minimum age of 18 years, and at least 1 year life expectancy

        Exclusion Criteria:

          -  Prior tricuspid valve replacement (annuloplasty is permitted)

          -  Intrinsic rhythm &lt; 30bpm

          -  Patients with permanent atrial fibrillation who undergo ablation of the
             atrioventricular node.

          -  Echocardiographic window of insufficient quality for measuring LVEF

          -  Life expectancy of &lt; 1year

          -  Pregnancy (women of childbearing potential will undergo pregnancy testing)

          -  Unable of unwilling to sign a patient informed consent form
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Haran Burri, Assoc. Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Geneva</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Angelo Auricchio, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fondazione Cardiocentro Ticino (Lugano)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christian Sticherling, Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>University Hospital of Basel</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Paul Erne, Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>Luzerner Kantonsspital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Peter Ammann, PD Dr.</last_name>
    <role>Study Chair</role>
    <affiliation>Cantonal Hospital of St. Gallen</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Frits Prinzen, Dr.</last_name>
    <role>Study Chair</role>
    <affiliation>Cardiovascular Research Institute, University of Maastricht</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cardiovascular Research Institute, University of Maastricht</name>
      <address>
        <city>Maastricht</city>
        <zip>6229</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital of Basel</name>
      <address>
        <city>Basel</city>
        <state>BS</state>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Geneva</name>
      <address>
        <city>Geneva</city>
        <state>GE</state>
        <zip>1211</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kantonsspital Luzern</name>
      <address>
        <city>Luzern</city>
        <state>LU</state>
        <zip>6000</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kantonsspital St-Gallen</name>
      <address>
        <city>St-Gallen</city>
        <state>SG</state>
        <zip>9007</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiocentro Ticino (Lugano)</name>
      <address>
        <city>Lugano</city>
        <state>TI</state>
        <zip>6900</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>October 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 10, 2012</study_first_submitted>
  <study_first_submitted_qc>February 14, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 17, 2012</study_first_posted>
  <last_update_submitted>May 11, 2016</last_update_submitted>
  <last_update_submitted_qc>May 11, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 13, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Geneva</investigator_affiliation>
    <investigator_full_name>Haran Burri, MD</investigator_full_name>
    <investigator_title>Assoc. Prof.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bradycardia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

